Similar articles

• The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.

  Goodman DS, Noble RP, Dell RB. Goodman DS, et al. J Clin Invest. 1973 Oct;52(10):2646-55. doi: 10.1172/JCI107457. J Clin Invest. 1973. PMID: 4729058 Free PMC article.
• Alterations in human serum alkaline phosphatase and its isoenzymes by hypolipidemic agents: colestipol and clofibrate.

  Probstfield JL, Statland BE, Gorman L, Hunninghake DB. Probstfield JL, et al. Metabolism. 1983 Aug;32(8):818-21. doi: 10.1016/0026-0495(83)90113-0. Metabolism. 1983. PMID: 6135138
• Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.

  Grundy SM, Mok HY. Grundy SM, et al. J Lab Clin Med. 1977 Feb;89(2):354-66. J Lab Clin Med. 1977. PMID: 833472
• The effect of hypolipidemic drugs on plasma lipoproteins.

  Levy RI. Levy RI. Annu Rev Pharmacol Toxicol. 1977;17:499-510. doi: 10.1146/annurev.pa.17.040177.002435. Annu Rev Pharmacol Toxicol. 1977. PMID: 326171 Review. No abstract available.
• Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.

  Heel RC, Brogden RN, Pakes GE, Speight TM, Avery GS. Heel RC, et al. Drugs. 1980 Mar;19(3):161-80. doi: 10.2165/00003495-198019030-00001. Drugs. 1980. PMID: 6988203 Review.